The infrastructure is now being built: the CMS-0057-F rule mandates FHIR-based PA APIs by January 2027, AHIP pledges are driving operational improvements since January 2026, and the Medicare GLP-1 Bridge demonstration starting July 2026 will test centralized electronic PA at unprecedented scale
Cognitive Benefits Acetyl-L-carnitine is particularly effective at enhancing brain function and may be useful in managing age-related cognitive decline and neurodegenerative diseases
AbbVies Rinvoq (Upadacitinib) reached $1.72 billion, up 57% YoYlikely to join the TOP10 soon
Lipotropic Compounds (often included) - Methionine, Inositol, and Choline: These compounds help break down fat, support liver function, and prevent fat accumulation
RXR agonists are also effective in the treatment of some neuropathies, such as Alzheimers disease 61 and Parkinsons disease in animal models 62
Agents such as semaglutide and tirzepatide improve metabolic parameters reliably without worsening baseline inflammatory disease activity ( Signals for disease modification Evidence for true disease modification remains low-certainty and hypothesis-generating, with recent observational signals serving as a foundation for potential disease modification rather than established therapeutic benefit ( A critical real-world evidence (RWE) appraisal of these cohorts reveals significant limitations
)
